Kazazian Asset Management’s ADC Therapeutics ADCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,300
Closed -$26.5K 59
2024
Q4
$26.5K Buy
+13,300
New +$26.5K 0.02% 53